Recovery Outcomes for Opiate Users. FRN Research Report November 2013

Similar documents
Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014

Foundations Recovery Network (FRN) Announces Groundbreaking Opiate Research Study Which Yields Compelling Results

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

Benefits of Dual Diagnosis Treatment: 2013 Patient Outcomes for Substance Use and Mental Health Disorders. FRN Research Report March/April 2014

YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

DDCAT Top Rating Shows Ongoing Commitment to Superior Services

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment

FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House

DrugFacts: Treatment Approaches for Drug Addiction

OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines

Treatment of Alcoholism

Performance Standards

Treatment Approaches for Drug Addiction

How To Choose A Drug Rehab Program

The National Community Detoxification Pilot

Treatment Approaches for Drug Addiction

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003

HIGH SUCCESS RATE OF BUTTERY REHABILITATION PROGRAMS

TREATMENT MODALITIES. May, 2013

FRN Research Report August 2011 Patient Outcomes and Relapse Prevention Up to One Year Post- Treatment at La Paloma Treatment Center

Phoenix House. Outpatient Treatment Services for Adults in Los Angeles and Orange Counties

Patient Satisfaction Scores

SUBSTANCE ABUSE OUTPATIENT SERVICES

Testimony of The New York City Department of Health and Mental Hygiene. before the

How. HOLiSTIC REHAB. Benefits You

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Prescriber Behavior, Pain Treatment and Addiction Treatment

Treatment Approaches for Drug Addiction

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

VENTURA COUNTY ALCOHOL & DRUG PROGRAMS

Treatment of opioid use disorders

John R. Kasich, Governor Orman Hall, Director

The Changing Face of Opioid Addiction:

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug

Levels of Care Guide

Care Management Council submission date: August Contact Information

Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program The West Virginia Model

Various therapies are used in the

A Breakthrough Approach to Integrating Substance Use and Mental Health Treatment. Susan Whitley, MD Director of Chemical Dependency Services

CSAT s Knowledge Application Program. KAP Keys. For Clinicians

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Fairfax-Falls Church Community Services Board

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.

American Society of Addiction Medicine

Evidence Based Approaches to Addiction and Mental Illness Treatment for Adults

Effective Treatment Strategies for Adolescent Heroin and Opiate Use. Chris Gleason, MA, CAADC, MAATP Director Rosecrance McHenry County

The efficacy of a relapse prevention programme in the treatment of heroin dependence in China

A Drug Policy for the 21st Century

Allyse Adams PC, LICDC Oriana House, Inc.

Effectiveness of Treatment The Evidence

EPIDEMIOLOGY OF OPIATE USE

Florida Alcohol and Drug Abuse Association. Presented to the Behavioral Health Quarterly Meeting Pensacola, Florida April 23, 2014

Educating Patients on the Effects of Substance Use, Its Impact on Their Health and Linkages to Treatment

CHAPTER 6: Substance Abuse and Mental Health A Comparison of Appalachian Coal Mining Areas to Other Areas within the Appalachian Region

Questions to Ask Each Rehab Facility. Includes Notes and Recommendations

Federal Response to Opioid Abuse Epidemic

Transitional Grant Area (TGA) Definition

Treatment Resources for Substance Use Disorders

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Co-occurring Disorder Treatment for Substance Abuse and Compulsive Gambling

ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) Introduction Types of Tier 4 Services Services provided at Tier 4

Prescription Drug Abuse

New York State Health Foundation Center for Excellence in Integrated Care (CEIC): Support for Health Care Institutions

Congressional Testimony. Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry

3.1 TWELVE CORE FUNCTIONS OF THE CERTIFIED COUNSELLOR

Addiction takes a toll not only on the

POLL. Co-occurring Disorders: the chicken or the egg. Objectives

The Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence

Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008

Appendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines

How To Know If You Can Get Help For An Addiction

Opiate Treatment for Aboriginal High School Students in Ontario

Addiction Psychiatry Fellowship Rotation Goals & Objectives

Frequently asked questions

Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

Medication is not a part of treatment.

Naltrexone and Alcoholism Treatment Test

Running Head: SUBSTANCE ABUSE TREATMENT WITH ADOLESCENTS. Substance Abuse Treatment Effectiveness with Adolescents. Krystle A. Cole.

July 2014 EDITION. Sanctuary Centers of Santa Barbara

CEIC Training Resource Guide

CADC-CAS STUDY GUIDE. Studying for the Exam. Exam Content Outline

Clinical Criteria Inpatient Medical Withdrawal Management Substance Use Inpatient Withdrawal Management (Adults and Adolescents)

Facility/Organizational Providers Approval Signatures: Available Upon Request

INSTRUCTIONS AND PROTOCOLS FOR THE IMPLEMENTATION OF CASE MANAGEMENT SERVICES FOR INDIVIDUALS AND FAMILIES WITH SUBSTANCE USE DISORDERS

Alcohol and Drug Abuse Treatment Centers

Opiate Abuse and Mental Illness

Health Care Service System in Thailand for Patients with Alcohol Use Disorder

Rates of Trauma-Informed Counseling at Substance Abuse Treatment Facilities: Reports From Over 10,000 Programs

Transcription:

Recovery Outcomes for Opiate Users FRN Research Report November 2013 Introduction Opiate use in America is at epidemic levels. The latest surveys show 4.5 million Americans using prescription painkillers non-medically and 620,000 using heroin (Substance Abuse and Mental Health Services Administration, 2012). As opiate abuse skyrockets, effective treatment options are crucial. Foundations Recovery Network (FRN) offers abstinence-based residential treatment for opiate users. Services are built on an integrated system of care that addresses substance use disorders and co-occurring mental health disorders. FRN offers residential and outpatient treatment in California, Georgia and Tennessee. Its treatment programs are considered national models for care: The FRN integrated treatment protocol is considered the gold standard in Dual Diagnosis treatment by Dartmouth Psychiatric Research Center and is noted for meeting best practice benchmarks in the SAMHSA s Treatment Improvement Protocol (TIP) 42. Abstinence-Based Treatment for Opiate Use Current debate is hot about the most effective, evidence-based treatment for opiates. This class of drugs, which includes heroin, non-medical methadone and prescription painkillers like OxyContin, is particularly challenging to treat. Opiate addiction has historically been considered harder to treat than other forms of addiction. Relapse rates are high among heroin users, often in the first month after detoxification (Smyth, Barry, Keenan, & Ducray, 2010). Several factors contribute to the high-relapse rate, according to research published in the Irish Medical Journal: Heavier use prior to treatment Failure to complete treatment Failure to enter follow-up or aftercare. Patients who complete treatment, develop positive support networks and participate in a form of follow-up care are more likely to remain abstinent. As part of its continued commitment to finding the most effective addiction treatment methods, FRN uses data from patients along with scientifically-proven research instruments to draw conclusions about its treatment protocols. A study of FRN s patients at their three private, abstinence-based residential treatment centers showed that the integrated system of care was equally effective for opiate users as it was for nonopiate substance users. The results are significant as the country moves toward drug policy changes that could impact opiate treatment regulations. All patients entering treatment at FRN s residential centers are offered the opportunity to participate in an ongoing study. Patients must sign Institutional Review Board approved consent

prior to participation, and the follow-up study includes phone interviews at intake and again at 30 days, six months and one year post-discharge. Pre- and post-treatment information is collected using the addiction severity index (ASI), a common assessment instrument that allows respondents to rate their current medical and psychiatric status using scales. Categories in the survey cover: alcohol use, drug use, psychiatric symptoms, legal issues, family/social relationships, medical issues and employment issues. Patients score the severity of a problem on a scale, with 0 indicating no problem and 5 indicating an extreme problem. Questions dealing with specific drug use are phrased to investigate the 30 days prior to the interview; for example, In the past 30 days, how many days have you used the following? The ASI is repeatedly demonstrated to be psychometrically sound and is considered a standard in the industry. Our Findings: Importance of Treating Opiate Addiction Opiate use is associated with a high-level of workplace absenteeism at a rate nearly three times higher than the average employee (Ruetsch, 2010). Nonmedical use of prescription painkillers increases violence and some types of crime (Catalano et al., 2011). Serious diseases also are associated with opiate use. Premature death from HIV and hepatitis is a risk, even after people stop opiate use (Butler, 2010). Study results were taken from a patient population of 1,972 people entering treatment. At six months, 1,495 patients (75.8%) provided follow-up information. Just less than half of patients (39.8%) reported opiate use in the 30 days prior to admission. These patients were then compared to non-opiate using patients. Opiate users treated at FRN s facilities lowered drug use and had similar outcomes to users of other drugs. Once patients left the residential facility, there were no significant differences in the number of emergency room visits or overnight stays in hospitals. Opiate users participated in 12- Step groups at the same rate as non-opiate users. One significant difference between the two groups was the likelihood of participating in outpatient substance abuse programs or halfway housing. Opiate users were more likely to utilize the services at 30 days, which is a significant factor in maintaining abstinence. Our Findings: ASI Treatment Outcomes for Opiate Users vs. Non-Opiate Users When ASI results for opiate users were compared with non-opiate users at intake, opiate users had significantly greater problems in several areas detected by the ASI: medical, drug use, legal issues and family/social relationships. At the six-month post-treatment mark, significantly fewer differences existed between the two groups, suggesting that the more severe and difficult to treat population of opiate users had normalized, resembling the average person in recovery. The integrated delivery model offered at FRN gives patients the tools and skills needed to improve in all areas of the ASI. In the graphs below, greater problem severity is indicated by higher scores. Therefore, greater decreases in score indicate greater significance of improvement in that area. Note that all areas were reported to be improved and remained significantly improved six months following treatment.

ASI Results for Opiate Users Higher scores indicate greater problem severity ASI Composite Scores 0.6 0.5 0.4 0.3 0.2 0.1 0 Our Findings: Psychological Symptoms for Opiate Users Mental health is monitored during residential treatment and during follow-up interviews as well. From intake to the six month mark, opiate users reported improvement in several psychological areas. The results are shown in the chart below. Again, positive change is reflected in reduced scores. All areas reported below demonstrated significant improvement. Psychological Changes for Opiate Users Reduction in score indicates positive improvement Cognitive Anxiety Psychological 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 Our Findings: Substance Use Results for Opiate Users

Patients at FRN reduced opiate use during their residential stay and maintained sobriety at the six month post-treatment mark. The following chart shows mean improvement in all areas of drug abuse. Not only did opiate users report fewer opiate uses, they also reported using fewer substances overall. Other opiates represents prescription painkillers. Substance Use Among Opiate Users 16 14 12 10 8 6 4 2 0 Our Findings: Satisfaction and Post-Treatment Results for Opiate Users Patients who reported opiate use not only experienced improvement in many areas of life, reduced psychological symptoms and reduced drug use, as noted above, but also reported high levels of overall satisfaction with their treatment experience at FRN facilities. Opiate users were particularly satisfied with the following four aspects of treatment at an FRN facility: Involvement in the individual treatment plan Group therapy 12-Step meetings Communication between staff and patients Conclusion Abstinence-based treatment for opiate use is a viable option for many people. The integrated treatment model offered at FRN gives opiate users the opportunity to learn the coping skills necessary for living without substances and treats the needs of the whole person, addressing important issues such as family/relationships, life skills and other areas necessary to help the opiate user recover for the long-term. Opiate users treated at FRN facilities report improvements in medical, psychiatric, drug use, legal, family and employment consistent with the average patient in recovery. Abstinence is attainable, and the FRN system of care can help opiate users achieve long-term recovery.

References Butler, S. B. (2010). Characteristics of prescription opioid abusers in treatment: prescription opioid history, age, use patterns and functional severity. Journal of Opioid Management, 239-41, 246-52. Catalano, R., White, H., Fleming, C., Haggerty, K. (2011). Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav. 2011 Jan Feb; 36(1-2): 79 86. doi: 10.1016/j.addbeh.2010.08.028 Cumberbatch, Z., Copersino, M., Stitzer, M., & Jones, H. (2004). Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment. The American Journal of Drug and Alcohol Abuse, 30 (2), 237-49. Ruetsch, C. (2010). Empirical view of opioid dependence. Journal of Managed Care Pharmacy, 16 (1-b), S9-S12. Smyth, B., Barry, J., Keenan, E., & Ducray, K. (2010). Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal, 103 (6), 176-9. Stotts, A., Northrup, T., & Norwood, W. (2013). Initial pilot test of a group-texting intervention to sustain opioid abstinence following residential detoxification and treatment. Journal of Addictive Behaviors, Therapy & Rehabilitation, 2 (3), 1-8. Substance Abuse and Mental Health Services Administration. (2012). Results from the 2012 National Survey on Drug Use and Health: Mental health findings. Office of Applied Studies, NSDUH Series H-39, No. SMA 10-4609. Retrieved November 19, 2013, from http://www.samhsa.gov/data/nsduh/2012summnatfinddettables/nationalfindings/nsduhre sults2012.htm#fig2.4